PLI for Pharma Industry

Pharma PLI Scheme Details:

The manufacturers of pharmaceutical goods registered in India will be grouped based on their Global Manufacturing Revenue (GMR) to ensure wider applicability of the scheme across the pharmaceutical industry and at the same time meet the objectives of the scheme. The qualifying criteria (Base Year: Financial Year 2019-20 shall be treated as the base year for computation of incremental sales of manufactured goods) for the three groups of applicants will be as follows-

I.Group A – Global Manufacturing Revenue of pharmaceutical goods more than or equal to Rs 5,000 crore. (>=5000Cr)

II.Group B – Global Manufacturing Revenue of pharmaceutical goods of Rs 500 crore up to Rs 5,000 crore. (>= 500Cr to 4999Cr)

III.Group C – Global Manufacturing Revenue of pharmaceutical goods less than Rs 500 crore. (=<500Cr)

The scheme shall cover pharmaceutical goods under three categories per the above stated target groups as mentioned below:-

Category 1

Category 2

Category 3

1. Bio-pharmaceuticals

2. Complex generic drugs

3. Patented drugs or drugs nearing patent expiry

4. Cell based or gene therapy drugs

5. Orphan drugs

6. Special empty capsules like HPMC, Pullulan, enteric etc.

7. Complex excipients

8. Phyto-pharmaceuticals

9. Other drugs as approved

1. Active Pharmaceutical Ingredients / Key Starting materials / Drug Intermediates

1. Repurposed drugs

2. Auto immune drugs, anti-cancer drugs, anti-diabetic drugs, anti- infective drugs, cardiovascular drugs, psychotropic drugs and anti- retroviral drugs

3. In-vitro diagnostic devices

4. Other drugs as approved

5. Other drugs not manufactured in India.

Read more details in our presentation below:-



More Posts

Digital Advertisement Policy

Digital Advertisement Policy

It is a significant move to harness the potential of digital media for government communication. This policy empowers the Central Bureau of Communication (CBC), the

Send Us A Message